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  Nitrogen is the most common pure element, present in nearly all relevant 
chemical compounds.  It is an essential component of the building blocks of life such as 
proteins, nucleic acids, amino acids and adenosine tri-phosphate.  There is a naturally 
occurring exchange between living organisms and the atmosphere which begins with the 
process of fixation.   Although nitrogen is naturally abundant, the strength of the triple 
bond in atmospheric nitrogen prevents its applicability in organic synthesis.  Therefore, 
the development of methods to place synthetic nitrogen into heteroatomic compounds 
plays an important role in the development of pharmacologically relevant scaffolds.   
  Contained within this manuscript are novel methods which utilize nitrones for 
various synthetic methods in order to incorporate nitrogen into a variety of heterocycles.  
The transfer agents used within this methodology are a variety of N-Substituted 
Hydroxylamines.  This work highlights the value of these nitrogen transfer agents as well 
as their chemoselectivity in synthesis. Herein is reported the methodological development 
of vinylisoxazolidines and isoxazolooxazines from vinylnitrones  
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  The early works of the Moura Letts Group have explored possible avenues for the 
utilization of substituted hydroxylamines as nitrogen transfer agents. With interests in the 
synthesis of small heterocycles, the GML group aimed to investigate the synthesis of 
five-membered heterocycles with varying functionality.  Isoxazolidines are 
fivemembered heterocycles containing an adjacent nitrogen and oxygen within the ring.  
These compounds have been isolated from a variety of natural sources, serve as 
intermediates in the synthesis current antibiotics, and have been recognized as therapeutic 
agents (Berthet et al. 2016).  Furthermore, Isoxazolooxazines are bridged bicycles 
containing two isoxazolidine rings with an interconnected five-membered carbon bridge.  
The synthesis of these desired five-membered heterocycles (Figure 1) were synthesized 
by utilizing nitrone substrates during their synthesis.  
 
Figure 1 
Heteroatomic Differences: Isoxazolidine (left), Isoxazolooxazines (right) 
 
 
. Previous members of the Moura Letts’ Group were in pursuit of a novel synthetic 
method to produce oxaziridines when the 1,3-Dipole, Nitrone was synthesized.  This 





simple aldehydes in polar aprotic solvents.  There were no indications that the desired 
Oxaziridine was produced in this reaction.  After characterization, it was determined that 
the major product obtained from these experiments was the 1,3-Dipole, Nitrone.  
 
Figure 2 




  Structurally, nitrones contain a positively charged nitrogen that makes four bonds.   
Most importantly, this nitrogen is bound to a negatively charged oxygen atom (Figure 2).  
The nitrogen-oxygen bond dipole has been identified as valuable synthetic intermediate 
as it allows for a broad range of chemical transformations (Macaluso & Hamer, 1964).  
These compounds have also been found to have value in other disciplines of chemistry 
besides organic such as analytical and pharmaceutical chemistry.   
  
1.1 The Pharmaceutical Significance of Nitrones  
  Oxidative stress is characterized by an imbalance between free-radical production 
and the body’s ability to neutralize them with antioxidants.  This can have very grave 




with oxidative stress can result in disruptions in cellular signaling, DNA mutations and 
even widespread apoptosis (Lennon, Martin & Cotter, 1991).  The health effects 
associated with these disturbances in cellular function have been reported consistently 
from various different research groups (Lobo, Phatak & Chandra, 2010).  Due to their 
ability to spin trap, it has been determined that nitrones neutralize free radicals providing 
a less reactive and thus less harmful compound.  Since there is evidence supporting that 
nitrones can be potential therapeutic agents, current research efforts have been made 
toward determining their potential in the pharmaceutical industry.  
  Phenyl tert-butylnitrone (PBN) and its derivatives have been identified in the 
literature as spin traps since the 1960’s.  Studies involving their ability to spin trap 
superoxide, hydrogen peroxide and hydroxyl free radicals that are responsible for 
oxygen-derived free radical damage in the body have been investigated.  Radical damage 
particularly has been identified in causing an increase in the permeability of the 
bloodbrain barrier (Chan, Schmidley, Fishman & Longar, 1984).  Initially commercial 
efforts were made to determine the efficiency of the 2,4-disulfonyl-phenylnitrone PBN 
derivative for the treatment acute ischemic strokes (Figure 3).  Although the preclinical 
trials displayed evidence that this could be a viable treatment option, it was determined 
after Phase 3 of clinical trials that this PBN derivative was ineffective in the treatment of 
acute ischemic strokes.  More recently, this derivative has been utilized as an anti-cancer 
agent in preclinical glioma models and has shown great promise alone and in 
combination with lanthionines as a therapeutic agent (Floyd, Castro Faria Neto, 










1.2 Methods for the Synthesis of Nitrones  
Previously, nitrones have been synthesized from oxaziridines under thermal 
conditions.  Due to the strain on the three-membered heterocycle containing a labile 
nitrogen-oxygen bond, the rearrangement to nitrone was made possible (Figure 4).  Since 
this transformation can be accelerated by an increasing the thermal conditions, there was 
an observed direct conversion in high yields to nitrone with no need of additives or 
workup.  Although this synthetic methodology was known, the construction of the 
starting oxaziridine was a major drawback, as we sought to develop a method that would 
be applicable for a library of compounds. The strained three-membered ring would not be 






Thermal Oxaziridine Rearrangement to Nitrone 
  
  
Additionally, it was noted in the literature that nitrones could be yielded via the 
mild oxidation of a tertiary hydroxylamine (Colladon, Scarso, & Strukul, 2008).  This 
method has been proven to be valuable in a variety of different synthetic approaches as it 
allows the nitrone functional group to be introduced into a sterically hindered scaffold.  
The Moura Letts’ Group has utilized this synthetic methodology, however when applied 
to the target library of molecular scaffolds, this synthetic method was low yielding and 
involved tedious work-up and purification.    
In order to make the desired nitrone synthesis high-yielding, robust and applicable 
to the desired library of compounds, the Moura Letts’ Group hypothesized that a 
conjugated-carbonyl condensation reaction with a hydroxylamine could be the most 
efficient synthetic route.  In this methodology both R and R’ are able to be functionalized 
by altering both the conjugated-carbonyl as well as the hydroxylamine source (Figure 5).   
After evaluating several literary sources, it was determined that this methodology would 





Selective Carbonyl Condensation with a Hydroxylamine 
  
 
1.3 Results and Discussion  
  Since the Moura Letts’ Group had previous experience in the realm of 
hydroxylamine chemistry, we sought to optimize a robust, high-yielding synthetic 
method for nitrones.  This reaction was first optimized by employing various solvents and 
it was determined that polar-aprotic solvents were optimal for yielding the desired 
product (Table 1).  The highest yields were seen utilizing acetonitrile and was therefore 





Table 1  
Optimization of Nitrone Condensation Reaction  
   
 
 
  With the objective of utilizing these nitrones for the synthesis of a library of 




methods to produce nitrones from alpha-beta unsaturated carbonyls.  Therefore going 
forward we employed a variety of both aliphatic and aromatic enals as the carbonyl 
source.  In comparison to aromatic enals, the aliphatic enals displayed significantly lower 
yields. Since these results were consistent across all of the aliphatic enals, it was 
determined that this reaction needed to be re-optimized with the objective being to 
increase the yields for aliphatic enal substrates.   
  Acetonitrile is considered to be a polar organic solvent which allows for high 
solubility of the organic carbonyl.  However, since the hydroxylamine is an inorganic 
salt, it is only slightly soluble in acetonitrile.  Therefore during optimization an aqueous 
media was employed for aliphatic carbonyl sources to allow for a slow introduction of the 
starting aliphatic carbonyl to the aqueous hydroxylamine layer upon vigorous stirring.   
This methodology afforded significantly higher yields for aliphatic nitrones (Table 2).    
  All in all the rates of reactions we observed were significantly faster than the 
previously reported reactions with unsaturated or aromatic enals. When monitored by thin 
layer chromatography, the alpha-beta unsaturated nitrones showed full conversion in one 





Table 2  






1.4 Conclusion  
  Alpha-beta unsaturated aliphatic and aromatic enals were converted to their 
corresponding nitrones displaying a broad scope.  Aromatic nitrones were afforded from 
aromatic alpha-beta unsaturated aldehydes through the use of acetonitrile as the solvent.  
Aliphatic nitrones were afforded from aliphatic alpha-beta unsaturated aldehydes by 
running the condensation on water, which allowed for the slow introduction of the 
organic carbonyl to the hydroxylamine.  All in all, the chemoselectivity in this reaction 
can be of use to the industry as these reaction conditions are robust, high-yielding and can 
be applied to a broad scope of substrates.   
1.5 Experimental  
  All of the reagents utilized in this experimentation were acquired from Aldrich 
Chemical, Acros Organics or Alfa Aesar and did not require further purification. All of 
the solvents used were obtained from EMD Miliphore DrySol and degassed with nitrogen 
to maintain inert reaction conditions. Reactions were performed in 4-ml glass vials with 
magnetic stirring. Thin layer chromatography analyses were performed on 0.25 mm E. 
Merck silica gel 60 F254 plates and observed under UV light (254 nm) and through 
staining with potassium permanganate (KMnO4). Silica flash chromatography analyses 
were performed on E. Merck 230–400 mesh silica gel 60. Automated chromatography 
was performed on an ISOLERA Prime instrument with 10 g. SNAP silica gel normal 
phase cartridges using a flow rate of 12.0 mL/min and a gradient of 0–46100% EtOAc in 
Heptanes over 12 column volumes with UV detection at 254 nm. NMR spectra were 
recorded on Varian Mercury II 400 MHz Spectrometer at 24 °C in CDCl3 unless 




CDCl3 (1H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed in Hz.  
  
1.5.1. General Method for the Synthesis of Nitrones 
In a 4-mL reaction vial, the alpha-beta unsaturated carbonyl (1.0 mmol, 1.0 
equivalent) and the Nbenzylhydroxylamine (1.1 mmol, 1.1 equivalent) were dissolved in 
3 mL of acetonitrile. The reaction was stirred at RT for 2 hours or until complete 
conversion of starting material was confirmed by thin layer chromatography. The organic 
was extracted with diethyl ether, 3-50 mL aliquots. The organic layer was washed with 3-
10 mL aliquots of aqueous (10%) sodium bicarbonate. The organic layer was dried with 
3-10 mL aliquots of saturated aqueous brine solution (NaCl). The organic layer was 
isolated and dried over anhydrous sodium sulfate, filtered, and concentrated by rotary 
evaporation to afford the crude product. The product was directly characterized unless 
traces of impurities required purification by automated silica gel flash chromatography.  
 
1.5.2. Synthesis of Nitrones from Table 2  
  
  
(1Z,2E)-N-benzyl-3-phenylprop-2-en-1-imine oxide (T3A) Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3a (82% 
yield) as a white solid. 1H NMR (400 MHz, Chloroform-d) δ 7.49 – 7.38 (m,  
8H), 7.35 – 7.29 (m, 3H), 7.21 (dd, J = 9.5, 0.7 Hz, 1H), 6.94 (d, J = 16.3 Hz, 1H), 4.95  
(s, 2H). 13C NMR (101 MHz, Chloroform-d) δ 138.37 , 136.46 , 129.25 , 129.17 , 






(1Z,2E)-N-benzyl-3-(4-methoxyphenyl)prop-2-en-1-imine oxide (T3A) 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 
20:1 heptanes/EtOAc to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3b 
(95% yield) as a white solid. 1H NMR (400 MHz, Chloroform-d) δ 7.49 – 7.38 (m, 
6H), 7.33 – 7.24 (m, 1H), 7.17 (dd, J = 9.5, 0.6 Hz, 1H), 7.00 – 6.77 (m, 3H),  
4.93 (s, 2H), 3.80 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 160.53 , 138.20 , 




(1Z,2E)-N-benzyl-3-(4-(dimethylamino)phenyl)prop-2-en-1-imine oxide (T3C) 
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 
20:1 heptanes/EtOAc to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3c 
(56% yield) as an orange solid. 1H NMR (400 MHz, Chloroform-d) δ 7.44 – 7.36 (m, 
6H), 7.29 – 7.22 (m, 1H), 7.14 (d, J = 9.6 Hz, 1H), 6.84 (d, J = 16.0 Hz, 1H), 6.66 – 
6.60 (m, 2H), 4.91 (s, 2H), 2.97 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ139.33 
, 137.49 , 133.40 , 129.16 , 128.89 , 128.86 , 128.73 , 113.90 , 111.98 , 68.72 ,  
40.15  






(1Z,2E)-N-benzyl-2-methyl-3-phenylprop-2-en-1-imine oxide (T3D) Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3c (56% 
yield) as an orange solid.  
  
  
(1Z,2E)-N-benzylbut-2-en-1-imine oxide (T3C) Purification by automated silica gel 
flash chromatography (10 g cartridge, 14 ml/min. 20:1 heptanes/EtOAc to 1:4 
Heptanes/EtOAc over 12 min) afforded the nitrone 3e (68% yield) as pale oil. 1H 
NMR (400 MHz, Chloroform-d) δ 7.37 (dtt, J = 5.2, 3.3, 2.0 Hz, 5H), 6.98 (d, J = 9.4  
Hz, 1H), 6.81 – 6.70 (m, 1H), 6.20 (dq, J = 16.0, 7.0 Hz, 1H), 4.86 (s, 2H), 1.86 (dd, J=  
6.9, 1.7 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 138.21 , 136.08 , 129.17 
,128.89 , 128.83 , 122.35 , 68.90 , 19.01 .  
  
  
(1Z,2E)-N-benzylhex-2-en-1-imine oxide (T3F) Purification by automated silica gel 
flash chromatography (10 g cartridge, 14 ml/min. 20:1 heptanes/EtOAc to 1:4 
Heptanes/EtOAc over 12 min) afforded the nitrone 3f (70% yield) as a pale oil. 1H NMR 
(400 MHz, Chloroform-d) δ 7.40 (dtd, J = 5.6, 2.7, 1.3 Hz, 4H), 6.98 (d, J = 9.4Hz, 1H), 
6.76 (ddt, J = 15.9, 9.5, 1.6 Hz, 1H), 6.19 (dt, J = 15.6, 7.1 Hz, 1H), 4.88 (s,2H), 2.17 




MHz, Chloroform-d) δ 143.37 , 136.29 , 129.25 , 128.91 , 128.86 , 121.13 ,68.93 , 35.34 
, 21.81 , 13.67 .  
  
  
(1Z,2E,4E)-N-benzylhexa-2,4-dien-1-imine oxide (T3G) Purification by automated 
silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 heptanes/EtOAc 
to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3g (85% yield) as a 




(1Z,2E,4E)-N-benzyldeca-2,4-dien-1-imine oxide (T3H) Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3h (90% 







(1Z,2E)-N-benzyl-3,7-dimethylocta-2,6-dien-1-imine oxide (T3I) Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 Heptanes/EtOAc over 12 min) afforded the nitrone 3i (92%yield) 
as a yellow oil. 1H NMR (400 MHz, Chloroform-d) δ 7.43 – 7.37 (m, 4H), 7.22(d, J = 
10.0 Hz, 1H), 6.60 (dq, J = 10.0, 1.3 Hz, 1H), 5.06 (ddtd, J = 5.6, 4.3, 2.7, 1.3Hz, 1H),  
4.90 (s, 2H), 2.16 (q, J = 5.8, 4.2 Hz, 4H), 1.76 (d, J = 1.2 Hz, 3H), 1.68 – 1.65(m, 3H),  
1.58 (d, J = 1.3 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 149.91 ,133.81 , 133.34 
, 129.05 , 128.85 , 128.74 , 123.18 , 115.87 , 69.11 , 40.37 , 26.28 , 25.64, 17.93 , 17.68.  
  































Chapter 2  
 
The Dipolar Cycloaddition of Nitrones to Isoxazolidines  
  
Isoxazolidines have been isolated as natural products, identified as important 
synthetic intermediates and resemble natural biological compounds. The potential value 
that isoxazolidines have as therapeutic agents has been recognized in multiple literary 
sources (Section 2.2). The isoxazolidine moiety consists of a 5-membered heterocylic 
ring containing a nitrogen-oxygen bond.  These compounds have been synthesized from 
nitrones through a dipolar cycloaddition with various dipolarophiles (Ricci, Gioia, Fini, 
Mazzanti, & Bernardi, 2009).  This synthetic methodology is known to be one of the most 
essential synthetic methods for the nitrone moeity (Hashimoto & Maruoka, 2015). There 
have been limitations recorded in the literature for this synthetic method, therefore we 
sought to develop a robust, regioselective synthesis to create a library of isoxazolidines 
from nitrones.  
  
2.1 Limitations of the Dipolar Cycloaddition  
  
The 1,3-dipolar cycloaddition of nitrones with a variety of alpha-beta unsaturated 
aldehydes has been identified as a successful mechanism for the synthesis of highly 
functionalized isoxazolidines.  Although these methods have been explored, there was not 
an existing mechanism that could predict which regioisomers and diastereomers would be 
formed from these reactions.  There are several different factors contributing to 




factor influencing the regioselectivity are the electronic effects of both the dipole and the 
dipolarophile utilized in the cycloaddition (Figure 6).    
 
Figure 6 
Possible Regioisomers Produced by the 1,3-Dipolar Cycloaddition  
  
 
There have been contradicting arguments within the literature about the 
regioselectivity of the dipole-dipolarophile interaction (Barba, C., Carmona, D., Garcia, J. 
I., et al. 2006). One of the major contributing factors to regioselectivity of this reaction is 
the electronic interactions between the nitrone dipole and the dipolarophile.  The effects 
of asymmetric dipolarophiles with varying electronic directionality results in a mixture of 
regioisomers, the 3,4-isoxazolidine and the 3,5-isoxazolidine.  Computational efforts have 
displayed a bias for the 3,5-isoxazolidine with carbonyls and cyano groups as the 
dipolarophile while the 3,4-isoxazolidine product is typically in produced in higher yields 
when employing an electron withdrawing group (Barba, C., Carmona, D., Garcia, J. I., et 
al. 2006). 
Efforts to improve the regioselectivity of this reaction include the utilization of 
Lewis Acid catalysts.  The major challenge of reactions employing Lewis Acid promoters 




as a strong base and thus has a high binding affinity for the catalyst.  Therefore, the 
nitrone competes with the dipolarophile causing reduced yields for the desired product.  
In order to increase binding affinity for the dipolarophile to the Lewis Acid catalyst, 
alpha-beta unsaturated aldehydes and ketones having bidentate or tridentate structures 
have been utilized (Figure 7).  In the presence of bidentate or tridentate dipolarophiles, 
nitrones are unable to compete to bind to the catalyst which can increase yields for the 
desired isozaxolidines (Barroso, S., Blay, G., Munoz, M. C., et al. 2011).    
 
Figure 7 
Dipolarophile (left), Nitrone (center), Bidentate Dipolarophile (left) with Increasing 
Binding Affinity from Left to Right 
  
 
Essentially, reviewing the techniques that researchers have utilized to overcome 
the limitations of this reaction is essential for improving the methodology.  The demand 
for a robust synthesis which allows for the prediction of regioselectivity still remains due 





 2.2 Biological Significance of Isoxazolidine Scaffolds   
  
Isoxazolidines have been recognized as privileged scaffolds in the fields of both 
organic chemistry and medicinal chemistry.  The isoxazolidine moiety has been isolated 
from several natural products, has been utilized in the synthesis of antimicrobial agents 
and shows potential for biological activity as it mimics the natural structures of 
nucleosides, carbohydrates, amino acids as well as some steroid analogs.    
The isoxazolidine scaffold has been extremely useful in the synthesis of natural 
products as it has been isolated from a variety of different species.  Zetekitoxin AB was 
the first alkaloid containing the isoxazolidine moiety extracted from a natural source; the  
Atelopus Zetecki a Panamanian frog species (Figure 8).  This guanidine alkaloid functions 
as a neurotoxin as it blocks voltage-gated sodium channels (Yotsu-Yamashita, M., Kim, 
Y. H., Dudley, S. C. et al. 2004). The five-membered heterocycle has also been extracted 
from the Alstonia pneumatophore as Alsmaphorazin A; identified as an inhibitor of nitric 
oxide production by lipopolysaccharide stimulated macrophages (Koyama, K., Hirasawa, 
Y., Nugroho, A. E., Hosoya, T., Hoe, T. C., Chan, K.-L., Morita, H. 2010).    
  









Beta-Lactams have been synthesized utilizing the isoxazolidine scaffold as an 
important synthetic intermediate.  Van Berkon et al. first developed the method to 
transform the isoxazolidine moiety through a base-induced ring contraction of 
nitrosoacetal, a 5,6,5-fused heterocyclic ring system.   The mechanism then involved the 
base-indeucd lactam deprotonation followed by the reductive cleavage of the nitrogen 
oxygen bond to afford the desired beta-lactam (van Berkom, L. W. A., Kuster, G. J. T., de 
Gelder, R., Scheeren, H. W. 2004).  Several other synthetic approaches to antimicrobial 
agents have been furthermore developed utilizing the isoxazolidine moiety contributing to 





2.3 Results and Discussion  
  
  The development of a library of 3-vinyl-4-formylisoxazolidines as well as 3vinyl-
5-formylisoxazolidines utilizing a 1,3-dipolar cycloaddition was an objective of high 
importance to the Moura Letts’ Group due to the pharmaceutical relevance of the 
isoxazolidine scaffold.  The nitrones utilized as the dipoles for the 1,3-dipolar 
cycloadditions were formed through the selective condensation of alpha-beta unsaturated 
carbonyls.  Since these nitrones have been fully isolated and characterized throughout the 
works of this paper, their usage as a reaction intermediate in the development of this 
method is strongly referenced.  
  In our beginning reactions we observed that hydroxylamines undergo selective 
condensation with alpha-beta unsaturated carbonyls without the need for troublesome 
purifications.  We envisioned that by introducing a more reactive alpha-beta unsaturated 
carbonyl in excess, we could utilize the steric effects of the dipolarophile and electronic 
effects of the nitrone to develop a method to determine which product would be 
produced. Therefore, during the initial optimization studies we reacted 
Nbenzylhydroxylamine with excess acrolein in attempt to perform both the selective 
condensation and 1,3-dipolar cycloaddition in one-pot.  All in all we found that the 
3vinyl-4-formylisoxazolidine was produced in a 20% yield and the 3-vinyl-
5formylisoxazolidine was produced in a 2% yield (Table 3-Entry-1).  Furthermore, we 
hypothesized that by first allowing a more bulky enal (Table 3-A) to undergo selective 
condensation with N-benzylhydroxylamine and then introducing the more reactive 
dipolarophile acrolein (Table 3-B), we could achieve the desirable chemeoselectivity 




Once the optimal enal-dipolarophile pair was discovered, we wanted to determine 
what conditions would promote better conversions while increasing diastereoselectivity.  
First we explored the thermal activation of this cycloaddition and found that by 
increasing the temperature to 80°C resulted in both increased reactivity and increased 
diastereoselectivity (Table 3, Entry 7).  Additionally, we employed several polar aprotic 
solvents and determined that acetonitrile was optimal for these reaction conditions (Table 
7, Entries 7 and 9-11).    
In an attempt to lower the thermal conditions required for this reaction, we 
investigated some Lewis Acid metal catalysts.  Although the reaction proceeded at an 
accelerated rate by utilizing 20 molar percent copper triflate, there was a decrease in 
regioselectivity and percent yield (Table 3-Entries 12-16).  Since regioselectivity and 
increased yield were the main objectives in optimizing these reactions, the thermal 




Table 3  
Optimization of the One-Pot Condensation-Cyclization  
  
 
Once the reaction was optimized we sought to create a library of isoxazolidines 
employing various dipolarophiles to access the generality of the reaction.  Trans-
4methoxycinnamaldehyde afforded optimal yields for the cycloaddition therefore we 
utilized it as the enal for the cycloadditions.  We were able to successfully react a variety 
of simple enals and enones as suitable dipolarophiles.  The diplarophiles substituted at the 




formylisoxazolidine regioisomer with trace amounts of other regioisomer detected (Table 
4, Entries 1-3).  Oppositely, dipolarophiles substituted at the alpha position afforded the 
3-vinyl-5-formylisoxazolidine regiosomer with complete selectivity.  Although there was 
an increase in regioselectivity for these dipolarophiles, some diastereoselectivity was 
compromised (Table 4, Entries 4-7).  
After we determined the generality of this reaction by employing simple enals and 
enones as the dipolarophile, we wanted to attempt cyclization with alternative carbonyl 
derivatives.  Acrylonitrile; similarly to the unsubstituted carbonyl acrolein, displayed 
complete selectivity for the 3,4-isoxazolidine regioisomer (Table 5, Entry 1).  
Additionally, diesters adopted the 3,4isoxazolidine regiosomer with complete selectivity 
and increase diastereoselectivity due to their symmetric structure (Table 5, Entries 4 and 
5).  Esters methyl methacrylate and tert-butyl acrylate showed complete selectivity for the 
3,5-isoxazolidine regioisomer similar to the alpha substituted dipolarophiles utilized 
previously (Table 5, Entries 2 and 3).   





Dipolarophile Scope: Simple Enals and Enones  
  





Dipolarophile Scope: Nitriles and Esters  
  
We next sought to broaden the scope by employing different enals to assess the 
electronic effects of the nitrone during cyclization.  Upon employing cyclohexenone as 
the dipolarophile for these reactions, we saw complete selectivity for the 3,7-VBI 













2.4 Conclusion  
  
A one-pot synthetic method was developed for the condensation and cyclization 
of nitrones from alpha-beta unsaturated carbonyls.  This method is significant because the 
scope applies to a variety of enals, enones, nitriles and esters.   Additionally, this method 
is appealing because it does not require troublesome purifications.   Ultimately it was 
determined that the regioselectivity could be predicted based upon the substitution pattern 
of the dipolarophile used in excess for the 1,3-dipolar cycloaddition.   
  
2.5 Experimental  
  
Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar and 
used without further purification. Solvents were obtained from EMD Miliphore DrySol 
and degassed with nitrogen. Reactions were performed in 4-mL glass vials with magnetic 
stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and 
visualized under UV light (254 nm) or by staining with potassium permanganate 
(KMnO4). Silica flash chromatography was performed on E. Merck 230–400 mesh silica 
gel 60. Automated chromatography was performed on a ISOLERA Prime instrument with 
10 g. SNAP silica gel normal phase cartridges using a flow rate of 12.0 mL/min and a 
gradient of 0–20% EtOAc in Heptanes over 12 column volumes with UV detection at  
254 nm. NMR spectra were recorded on Varian Mercury II 400 MHz Spectrometer at 24  
°C in CDCl3 unless otherwise indicated. Chemical shifts are expressed in ppm 74 relative 
to solvent signals: CDCl3 (1H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed 




2.5.1. General Method for the Synthesis of Vinyl-Isoxazolidines 
In a 4- mL glass vial, 1 mMol enal and 1.1 eq. hydroxylamine were dissolved in 1 
mL acetonitrile. The mixture was stirred at room temperature for five minutes after which 
3 molar equivalents dipolarphile was added. The reaction was stirred vigorously at 80°C 
for 16hours. The organic was extracted with 150 mL diethyl ether. The organic layer was 
washed with 3-25 mL aliquots of (10%) aqueous sodium bicarbonate. The organic layer 
was dried with 3-25 mL aliquots of saturated aqueous brine solution (NaCl). The organic 
layer is finally isolated and dried over anhydrous sodium sulfate, filtered, and concentrated 
by rotary evaporation to afford the crude product. The crude product is filtered through 
silica gel over a gradient of 4:1 Heptanes/EtOAc over 12 column volumes to obtain the 
respective isoxazolidine in good to excellent yields.  




(E)-2-benzyl-3-(4-methoxystyryl)isoxazolidine-4-carbaldehyde(T2A):  Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2a  
(115 mg, 90%) as a yellow oil. TLC: Rf 0.20 (3:1 heptanes/EtOAc). 1H NMR (400 MHz,  
CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H),  
6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J  
= 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, 3H), 3.78 (d, J = 14.1 Hz,  
1H), 3.63 (d, J = 7.4 Hz, 1H), 3.35 – 3.29 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 











(E)-2-benzyl-3-(4-methoxystyryl)-5-propylisoxazolidine-4-carbaldehyde (T2B):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2b  
(100 mg, 70%) as a yellow oil. TLC: Rf 0.38 (3:1 heptanes/EtOAc). 1H NMR (400  
MHz, CDCl3) δ 9.75 (dd, J = 2.7, 0.7 Hz, 1H), 7.52 – 7.24 (m, 7H), 6.96 – 6.84 (m, 2H),  
6.54 (d, J = 15.8 Hz, 1H), 6.06 (dd, J = 15.7, 8.5 Hz, 1H), 4.51 – 4.17 (m, 1H), 4.13 (d, J  
= 14.3 Hz, 1H), 3.81 (d, J = 0.7 Hz, 3H), 3.77 – 3.61 (m, 1H), 3.01 (ddd, J = 7.8, 5.4, 2.7 
Hz, 1H), 1.87 (dddd, J = 13.4, 9.7, 7.8, 5.6 Hz, 1H), 1.60 (ddt, J = 13.5, 9.6, 5.9 Hz, 1H),  
1.47 – 1.30 (m, 2H), 0.93 (td, J = 7.4, 3.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
198.89, 133.85, 128.55, 128.16, 127.81, 127.08, 123.69, 114.03, 76.92, 67.75, 55.30, 




(E)-2-benzyl-3-(4-methoxystyryl)-4-methylisoxazolidine-4-carbaldehyde (T2C):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2c  
(165 mg, 90%) as a yellow oil. TLC: Rf 0.35 (3:1 heptanes/EtOAc). 1H NMR (400  
MHz, CDCl3) δ 9.59 (s, 1H), 7.39 (d, J = 7.1 Hz, 2H), 7.35 – 7.29 (m, 4H), 7.25 (tt, J =  
6.0, 1.6 Hz, 1H), 6.93 – 6.78 (m, 2H), 6.53 (d, J = 15.8 Hz, 1H), 5.89 (ddd, J = 15.8, 8.8,  
0.6 Hz, 1H), 4.19 (d, J = 14.8 Hz, 1H), 3.81 (d, J = 0.6 Hz, 3H), 3.76 (d, J = 14.8 Hz,  
1H), 3.43 (q, J = 8.3 Hz, 1H), 2.52 (dd, J = 12.7, 7.8 Hz, 1H), 2.25 (dd, J = 12.7, 8.4 Hz, 
1H), 1.30 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 205.12, 133.59, 128.35, 128.18, 




( T2B) DJQ - 407  
  
  






(E)-1-(2-benzyl-3-(4-methoxystyryl)isoxazolidin-4-yl)ethan-1-one (T2D): Purification 
by automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2d (180 
mg, 80%) as a yellow oil. TLC: Rf 0.45 (3:1 heptanes/EtOAc). 1H NMR (400 MHz,  
CDCl3) δ 7.39 (d, J = 7.1 Hz, 2H), 7.34 (ddd, J = 4.3, 2.5, 1.3 Hz, 4H), 7.29 – 7.23 (m,  
1H), 6.92 – 6.82 (m, 2H), 6.56 (d, J = 15.8 Hz, 1H), 5.92 (dd, J = 15.8, 8.6 Hz, 1H), 4.29  
(dd, J = 9.5, 4.7 Hz, 1H), 4.18 (d, J = 14.1 Hz, 1H), 3.81 (d, J = 0.8 Hz, 3H), 3.70 (d, J =  
14.1 Hz, 1H), 3.35 (q, J = 8.3 Hz, 1H), 2.72 (ddd, J = 12.8, 9.4, 7.8 Hz, 1H), 2.39 (ddd, J  
= 13.0, 8.5, 4.7 Hz, 1H), 2.11 (d, J = 0.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
133.80, 128.91, 128.14, 127.71, 127.21, 124.54, 114.04, 80.49, 69.42, 59.76, 55.30, 





(E)-1-(2-benzyl-3-(4-methoxystyryl)isoxazolidin-4-yl)propan-1-one (T2E):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2e  
(105 mg, 70%) as a pale oil. TLC: Rf 0.50 (3:1 heptanes/EtOAc). 1H NMR (400 MHz,  
CDCl3) δ 7.41 – 7.22 (m, 8H), 6.89 – 6.83 (m, 2H), 6.54 (d, J = 15.8 Hz, 1H), 5.91 (dd, J  
= 15.9, 8.5 Hz, 1H), 4.33 (dd, J = 9.4, 4.9 Hz, 1H), 4.16 (d, J = 14.1 Hz, 1H), 3.81 (d, J =  
0.7 Hz, 3H), 3.70 (d, J = 14.1 Hz, 1H), 3.35 (q, J = 8.3 Hz, 1H), 2.76 – 2.68 (m, 1H),  
2.65 – 2.56 (m, 1H), 2.47 (ddd, J = 11.5, 7.2, 4.4 Hz, 1H), 2.42 – 2.36 (m, 1H), 0.95 (td, J 
= 7.3, 0.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 159.51, 137.57, 133.73, 128.89, 
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(E)-2-benzyl-3-(4-methoxystyryl)hexahydrobenzo[d]isoxazol-4(2H)-one (T2F):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2f  
(110 mg, 65%) as a yellow oil. TLC: Rf 0.15 (3:1 heptanes/EtOAc). 1H NMR (400  
MHz, CDCl3) δ 7.41 – 7.35 (m, 2H), 7.35 – 7.27 (m, 4H), 7.25 – 7.21 (m, 1H), 6.88 – 
6.82 (m, 2H), 6.59 (d, J = 15.8 Hz, 1H), 6.10 – 6.01 (m, 1H), 4.57 (dt, J = 7.7, 4.3 Hz,  
1H), 4.10 (d, J = 14.1 Hz, 1H), 3.88 – 3.79 (m, 5H), 3.00 (t, J = 6.7 Hz, 1H), 2.51 (dt, J =  
17.0, 5.1 Hz, 1H), 2.34 (ddd, J = 16.6, 10.2, 6.1 Hz, 1H), 2.07 – 1.97 (m, 1H), 1.96 – 1.88 
(m, 2H), 1.87 – 1.79 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 137.48, 133.11, 128.95, 
128.20, 127.74, 127.19, 125.05, 113.94, 70.51, 60.81, 55.28, 39.92, 26.47, 19.05.  
  
  




(E)-2-benzyl-3-(4-methoxystyryl)isoxazolidine-4-carbonitrile (T3A): Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2g (80 
mg, 90%) as a pale oil. TLC: Rf 0.20 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, 
CDCl3) δ 7.42 – 7.38 (m, 2H), 7.36 – 7.24 (m, 5H), 6.95 – 6.83 (m, 2H), 6.68 (d, J = 
15.8  
Hz, 1H), 6.20 (dd, J = 15.8, 8.9 Hz, 1H), 4.30 (t, J = 8.6 Hz, 1H), 4.18 (d, J = 14.3 Hz,  
1H), 4.08 (dd, J = 8.4, 6.7 Hz, 1H), 3.82 (d, J = 0.5 Hz, 3H), 3.71 (d, J = 14.3 Hz, 1H),  
3.61 (td, J = 8.5, 6.7 Hz, 1H), 3.51 (t, J = 8.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 
136.95, 136.61, 128.74, 128.44, 128.30, 128.22, 127.46, 119.86, 114.09, 69.99, 68.68, 
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Tert-butyl (E)-2-benzyl-3-(4-methoxystyryl)isoxazolidine-4-carboxylate (T3B):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2h  
(90 mg, 90%) as a pale oil. TLC: Rf 0.56 (3:1 heptanes/EtOAc). 1H NMR (400 MHz,  
CDCl3) δ 7.44 – 7.40 (m, 2H), 7.31 (dd, J = 8.3, 6.0 Hz, 4H), 7.26 – 7.22 (m, 1H), 6.89 – 
6.84 (m, 2H), 6.56 (d, J = 15.9 Hz, 1H), 5.99 (dd, J = 15.8, 8.2 Hz, 1H), 4.50 (dd, J = 8.2,  
5.2 Hz, 1H), 4.14 – 4.01 (m, 2H), 3.81 (d, J = 0.8 Hz, 3H), 3.67 – 3.59 (m, 1H), 2.57 (t, J 
= 8.4 Hz, 2H), 1.51 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 137.79, 133.31, 128.98, 






(T3C): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the 
isoxazolidine 2i (105 mg, 90%) as a yellow oil. TLC: Rf 0.50 (3:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3) δ 7.47 – 7.37 (m, 2H), 7.41 – 7.17 (m, 6H), 6.91 – 6.80 (m,  
2H), 6.51 (d, J = 15.9 Hz, 1H), 5.95 (ddd, J = 15.8, 8.7, 1.3 Hz, 1H), 4.24 – 4.05 (m, 1H),  
3.89 – 3.71 (m, 8H), 3.44 (q, J = 8.4 Hz, 1H), 2.83 (ddd, J = 12.8, 8.6, 1.3 Hz, 1H), 2.31  
(ddd, J = 12.9, 8.0, 1.4 Hz, 1H), 1.57 (s, 1H), 1.50 (d, J = 1.3 Hz, 3H). 13C NMR (101 
MHz, Chloroform-d) δ 159.46, 137.53, 133.50, 128.19, 128.01, 127.69, 126.77, 124.72, 
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Dibutyl (E)-2-benzyl-3-(4-methoxystyryl)isoxazolidine-4,5-dicarboxylate (T3D):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2j  
(120 mg, 90%) as a white solid. TLC: Rf 0.62 (3:1 heptanes/EtOAc). 1H NMR (400  
MHz, CDCl3) δ 7.43 – 7.37 (m, 2H), 7.34 – 7.28 (m, 4H), 7.26 – 7.21 (m, 1H), 6.91 – 
6.83 (m, 2H), 6.63 (d, J = 15.8 Hz, 1H), 5.97 (dd, J = 15.8, 8.5 Hz, 1H), 4.21 – 4.14 (m, 
2H), 4.12 – 4.02 (m, 4H), 3.91 (t, J = 9.0 Hz, 1H), 3.81 (d, J = 0.6 Hz, 3H), 3.67 – 3.60 
(m, 1H), 1.67 – 1.54 (m, 4H), 1.44 – 1.30 (m, 4H), 0.91 (ddd, J = 29.9, 7.6, 7.1 Hz, 6H). 
13C NMR (101 MHz, CDCl3) δ 137.34, 135.24, 128.99, 128.25, 127.87, 127.27, 122.01, 





Diethyl (E)-2-benzyl-3-(4-methoxystyryl)isoxazolidine-4,5-dicarboxylate (T3E):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2k  
(118 mg, 90%) as a white solid. TLC: Rf 0.35 (3:1 heptanes/EtOAc). 1H NMR (400  
MHz, CDCl3) δ 7.46 – 7.43 (m, 2H), 7.33 (dq, J = 8.7, 2.3, 1.5 Hz, 4H), 7.29 (d, J = 1.5 
Hz, 1H), 6.88 – 6.85 (m, 2H), 6.62 (d, J = 15.8 Hz, 1H), 6.02 (dd, J = 15.9, 8.6 Hz, 1H),  
4.87 (d, J = 4.3 Hz, 1H), 4.24 (tdd, J = 15.0, 7.5, 3.7 Hz, 5H), 3.86 (d, J = 15.2 Hz, 1H),  
3.81 (s, 3H), 3.74 (dd, J = 8.2, 4.3 Hz, 1H), 3.65 – 3.58 (m, 1H), 1.31 (d, J = 7.1 Hz, 3H), 
1.25 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 135.12, 128.10, 128.08, 











(E)-2-benzyl-3-(4-methoxystyryl)-5-methylisoxazolidine-4-carbaldehyde (T3F):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 2l  
(85 mg, 70%) as a pale oil. TLC: Rf 0.31 (3:1 heptanes/EtOAc). 1H NMR (400 MHz,  
CDCl3) δ 9.76 (t, J = 2.0 Hz, 1H), 7.39 – 7.25 (m, 9H), 6.88 – 6.85 (m, 2H), 6.53 (d, J =  
15.9 Hz, 1H), 6.13 – 6.05 (m, 1H), 4.52 – 4.47 (m, 1H), 4.13 (d, J = 14.2 Hz, 1H), 3.85  
(d, J = 14.3 Hz, 1H), 3.81 (d, J = 1.5 Hz, 3H), 3.75 (d, J = 6.7 Hz, 1H), 2.97 (s, 1H), 1.43 
(dd, J = 6.2, 1.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 198.76, 133.80, 128.56, 
128.23, 127.81, 127.15, 123.75, 114.04, 73.10, 68.94, 59.37, 55.30, 20.72.  
  





(E)-2-benzyl-3-styrylhexahydrobenzo[d]isoxazol-4(2H)-one (T4A): Purification by 
automated silica gel flash chromatography (10 g cartridge, 14 ml/min. 20:1 
heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 3a (165 
mg, 92%) as a white solid. TLC: Rf 0.25 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, 
CDCl3) δ 7.39 (dd, J = 8.2, 6.5 Hz, 4H), 7.32 (t, J = 7.4 Hz, 4H), 7.28 – 7.23 (m, 2H),  
6.67 (d, J = 15.9 Hz, 1H), 6.22 (dd, J = 15.9, 7.9 Hz, 1H), 4.59 (dt, J = 7.8, 4.3 Hz, 1H),  
4.10 (d, J = 14.0 Hz, 1H), 3.93 (dd, J = 7.9, 5.9 Hz, 1H), 3.87 (d, J = 14.0 Hz, 1H), 3.01  
(t, J = 6.6 Hz, 1H), 2.52 (dt, J = 16.8, 5.0 Hz, 1H), 2.36 (ddd, J = 16.5, 10.2, 6.2 Hz, 1H), 
2.09 – 1.99 (m, 1H), 1.93 (dq, J = 9.8, 4.4 Hz, 2H), 1.84 (ddd, J = 14.0, 7.1, 3.7 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 133.49, 128.99, 128.55, 128.23, 127.82, 127.49, 127.25, 
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(E)-2-benzyl-3-(4-(dimethylamino)styryl)hexahydrobenzo[d]isoxazol-4(2H)-one 
(T4B): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the 
isoxazolidine 3b (178 mg, 70%) as a red oil. TLC: Rf 0.19 (3:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3) δ 7.40 – 7.28 (m, 6H), 7.25 – 7.22 (m, 1H), 6.67 (dd, J = 8.9,  
2.6 Hz, 2H), 6.56 (d, J = 15.8 Hz, 1H), 5.98 (ddd, J = 15.7, 8.1, 1.0 Hz, 1H), 4.57 (dt, J =  
7.6, 4.2 Hz, 1H), 4.12 (d, J = 14.1 Hz, 1H), 3.80 (d, J = 10.6 Hz, 1H), 3.01 (t, J = 6.9 Hz,  
1H), 2.96 (d, J = 1.0 Hz, 6H), 2.54 – 2.30 (m, 3H), 2.09 – 1.92 (m, 2H), 1.91 – 1.82 (m, 
2H). 13C NMR (101 MHz, CDCl3) δ 128.98, 128.17, 127.56, 127.13, 122.53, 112.32, 





(T4C): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the 
isoxazolidine 3c (105 mg, 72%) as a pale oil. TLC: Rf 0.33 (3:1 heptanes/EtOAc). 1H 
NMR (400 MHz, CDCl3) δ 7.42 – 7.20 (m, 10H), 6.94 – 6.53 (m, 1H), 4.57 – 4.47 (m,  
1H), 4.25 – 4.02 (m, 1H), 3.93 – 3.63 (m, 2H), 3.48 – 2.92 (m, 1H), 2.53 – 2.02 (m, 3H),  
1.89 (s, 3H), 1.89 – 1.78 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 209.40, 135.35, 
132.30, 129.06, 128.99, 128.87, 128.16, 128.01, 127.17, 126.47, 75.19, 60.82, 59.16, 













(T4D): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes over 
12 column volumes) yielded the isoxazolidine 4d (mass, % yield) as a yellow oil. TLC: 
Rf 0.20 (3:1 heptanes/EtOAc).  1H NMR (400 MHz, Chloroform-d) δ 7.36 – 7.28 (m, 
4H), 7.25 – 7.21 (m, 1H),  
5.19 (ddd, J = 9.4, 2.5, 1.3 Hz, 1H), 4.55 – 4.48 (m, 1H), 3.98 (d, J = 14.1 Hz, 1H), 3.87 
(s, 1H), 3.76 (d, J = 14.1 Hz, 1H), 2.88 (t, J = 7.3 Hz, 1H), 2.47 (dt, J = 17.0, 5.1 Hz, 1H), 
2.36 – 2.28 (m, 1H), 2.08 – 1.98 (m, 1H), 1.88 – 1.78 (m, 3H), 1.71 (dd, J = 16.9, 1.3 Hz, 
6H). 13C NMR (101 MHz, cdcl3) δ 209.84, 137.68, 136.10, 128.81, 128.13, 127.08, 
76.57, 66.73, 61.00, 39.49, 26.65, 26.05, 18.67, 18.47.  
  
 
(T4E) DJQ-456  
  
(E)-2-benzyl-3-(pent-1-en-1-yl)hexahydrobenzo[d]isoxazol-4(2H)-one (T4E):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 3d  
(110 mg, 80%) as a yellow oil. TLC: Rf 0.42 (3:1 heptanes/EtOAc). 1H NMR (400  
MHz, CDCl3) δ 7.36 (dd, J = 5.9, 1.9 Hz, 3H), 7.31 (d, J = 7.1 Hz, 2H), 5.70 (dt, J =  
15.3, 6.8 Hz, 1H), 5.46 – 5.39 (m, 1H), 4.50 (dt, J = 8.0, 4.2 Hz, 1H), 4.05 (d, J = 14.1  
Hz, 1H), 3.75 (d, J = 14.1 Hz, 1H), 3.58 (t, J = 7.6 Hz, 1H), 2.92 (t, J = 7.2 Hz, 1H), 2.50  
– 2.45 (m, 1H), 2.31 (ddd, J = 16.7, 10.1, 6.2 Hz, 2H), 2.01 (d, J = 7.3 Hz, 2H), 1.90 – 
1.81 (m, 3H), 1.38 (d, J = 7.3 Hz, 2H), 0.87 (d, J = 7.3 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 135.84, 128.92, 128.16, 127.12, 70.71, 60.66, 39.64, 34.39, 26.56, 22.13, 
18.77, 13.59.  
  
  







(T4F) DJQ-497  
  
(E)-2-benzyl-3-(prop-1-en-1-yl)hexahydrobenzo[d]isoxazol-4(2H)-one (T4F):  
Purification by automated silica gel flash chromatography (10 g cartridge, 14 ml/min.  
20:1 heptanes/EtOAc to 1:4 heptanes/EtOAc over 12 min) yielded the isoxazolidine 3e  
(209 mg, 70%) as a yellow oil. TLC: Rf 0.38 (3:1 heptanes/EtOAc). 1H NMR (400 MHz,  
CDCl3) δ 7.38 – 7.24 (m, 5H), 5.80 – 5.66 (m, 1H), 5.46 (ddq, J = 15.2, 8.2, 1.5 Hz, 1H),  
4.51 (ddt, J = 11.9, 8.1, 4.4 Hz, 1H), 4.08 – 4.00 (m, 1H), 3.77 (dd, J = 19.9, 14.0 Hz,  
1H), 3.63 – 3.41 (m, 1H), 2.90 (q, J = 8.8, 8.0 Hz, 1H), 2.47 (dt, J = 16.4, 5.0 Hz, 1H),  
2.35 – 2.26 (m, 1H), 2.00 (dddd, J = 15.7, 7.7, 3.6, 1.8 Hz, 1H), 1.89 – 1.75 (m, 3H), 1.70 
(ddd, J = 6.3, 4.3, 1.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 130.57, 128.91, 128.86, 




T4G (DJQ-619)  
  
(3S,3aR,7aS)-2-benzyl-3-((E)-2,6-dimethylhepta-1,5-dien-1- 
yl)hexahydrobenzo[d]isoxazol-7(4H)-one (T4G): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14 ml/min. 2 column volumes of 100% Heptanes 
followed by 0-33% EtOAc in Heptanes over 12 column volumes) yielded the 
isoxazolidine 4g (mass, % yield) as a yellow oil. TLC: Rf 0.20 (3:1 heptanes/EtOAc). 
1H NMR (400 MHz, Chloroform-d) δ 7.37 – 7.21 (m, 5H), 5.20 (dq, J = 9.2, 1.4 Hz,  
1H), 5.13 – 4.96 (m, 1H), 4.52 (dt, J = 8.4, 4.4 Hz, 1H), 3.97 (d, J = 14.0 Hz, 1H), 3.89 (t,  
J = 8.7 Hz, 1H), 3.80 – 3.68 (m, 1H), 2.88 (t, J = 7.3 Hz, 1H), 2.47 (dt, J = 16.9, 5.2 Hz,  
1H), 2.31 (ddd, J = 16.7, 9.7, 6.2 Hz, 1H), 2.20 – 1.91 (m, 6H), 1.87 – 1.75 (m, 3H), 1.72  
– 1.56 (m, 9H). 13C NMR (101 MHz, cdcl3) δ 209.64, 137.62, 131.61, 128.83, 128.63, 
128.09, 127.05, 123.80, 76.68, 66.47, 61.07, 39.69, 39.48, 26.60, 26.24, 25.63, 18.69, 









T4H (DJQ-418)  
  
(3R,3aR,7aS)-2-benzyl-3-(prop-1-en-2-yl)hexahydrobenzo[d]isoxazol-7(4H)-one 
(T4H): Purification by automated silica gel flash chromatography (10 g cartridge, 14 
ml/min. 2 column volumes of 100% Heptanes followed by 0-33% EtOAc in Heptanes 
over 12 column volumes) yielded the isoxazolidine 4h (mass, % yield) as a yellow oil. 
TLC: Rf 0.20 (3:1 heptanes/EtOAc). 1H NMR (400 MHz, Chloroform-d) δ 7.37 – 7.21  
(m, 5H), 5.20 (dq, J = 9.2, 1.4 Hz, 1H), 5.13 – 4.96 (m, 1H), 4.52 (dt, J = 8.4, 4.4 Hz,  
1H), 3.97 (d, J = 14.0 Hz, 1H), 3.89 (t, J = 8.7 Hz, 1H), 3.80 – 3.68 (m, 1H), 2.88 (t, J =  
7.3 Hz, 1H), 2.47 (dt, J = 16.9, 5.2 Hz, 1H), 2.31 (ddd, J = 16.7, 9.7, 6.2 Hz, 1H), 2.20 –  
1.91 (m, 6H), 1.87 – 1.75 (m, 3H), 1.72 – 1.56 (m, 9H). 13C NMR (101 MHz, cdcl3) δ 
209.64, 137.62, 131.61, 128.83, 128.63, 128.09, 127.05, 123.80, 76.68, 66.47, 61.07, 





yl)hexahydrobenzo[d]isoxazol7(4H)-one (T4I): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14 ml/min. 2 column volumes of 100% Heptanes 
followed by 0-33% EtOAc in Heptanes over 12 column volumes) yielded the 
isoxazolidine 4i (mass, % yield) as a yellow oil. TLC: Rf 0.20 (3:1 heptanes/EtOAc). 1H 
NMR (400 MHz, Chloroform-d) δ 7.37 – 7.23 (m, 5H), 6.25 (dd, J = 15.2, 10.4 Hz, 1H), 
6.08 – 5.96 (m, 1H), 5.80 – 5.65  
(m, 1H), 5.52 (dd, J = 15.2, 8.1 Hz, 1H), 4.51 (ddt, J = 11.5, 7.7, 4.2 Hz, 1H), 4.04 (d, J =  
14.1 Hz, 1H), 3.74 (d, J = 14.1 Hz, 1H), 3.66 (t, J = 7.2 Hz, 1H), 2.92 (dd, J = 8.7, 5.2 Hz,  
1H), 2.51 – 2.43 (m, 1H), 2.35 – 2.27 (m, 1H), 2.03 – 1.95 (m, 1H), 1.91 – 1.84 (m, 2H),  
1.80 (ddd, J = 6.9, 5.4, 2.5 Hz, 1H), 1.77 – 1.73 (m, 3H). 13C NMR (101 MHz, cdcl3) δ 
209.31, 137.49, 134.26, 130.62, 130.53, 128.85, 128.13, 127.11, 76.49, 70.31, 60.74, 
39.73, 26.46, 18.84, 18.07.  
  
























































































Chapter 3  
 
Synthesis of Isoxazolooxazines  
  
3.1 Intermolecular Cycloadditions of Vinyl Isoxazolidines  
  Reported earlier in this document was the synthesis of nitrones from various enals 
utilizing a variety of hydroxylamines as nitrogen transfer agents.  With this knowledge in 
mind, we attempted to form the cooresponding nitrone from both the 3vinyl-4-
formylisoxazolidines (3,4-VFI) and 3-vinyl-5-formylisoxazolidines (3,5-VFI) reported in 
Chapter 2 (Figure 9). 
 
Figure 9 
Nitrones formed from 3,4-VFI (left) and 3,5-VFI (right) 
 
 
The further objective of creating these nitrones was to perform an intermolecular 
cycloadditon with various dipolarophiles in order to create biisoxazolidines, 
terisoxazolidines and eventually tetraisoxazoles. (Figure 10). The reactions would 
proceed by creating the cooresponding nitrone followed by an intermolecular 
cycloaddition utilizing an alpha-beta unsaturated aldehyde or ketone as a diploarophile to 
create biisoxazolidines and terisoxazolidines.  To create the desired tetraisoxazoles, the 





bond of the terisoxazolidine.  These reactions would be robust and would encompass a 




Scope Utilizing Acrolein as the Dipolarophile: Biisoxazolidines (left), 
Terisoxazolidine (center) and Tetraisoxazoles (right) 
 
 
While attempting to create the nitrone of the 3-vinyl-5-formylisoxazolidine, we 
observed a different reaction was taking place.  Instead of forming the expected nitrone, 
by analysis of the crude NMR the reaction was immediately performing an 
intermolecular cycloaddition once introduced to the hydroxylamine (Figure 11).  Once 
seeing these consistent results among several of the 3-vinyl-5-formylisoxazoldine 











3.2 Synthetic Relevance  
  
Upon the realization that the 3-vinyl-5-formylisoxazolidine regioisomer could 
undergo an intramolecular cycloaddition, we saw an opportunity to create 
carbacycles.  By cleaving the two nitrogen oxygen bonds within the fused ring system 
of the isoxazolooxazine, we could obtain a stereochemically dense five-membered 
ring containing five stereocenters with electron rich substituents.  Carbacycles hold 
significant pharmaceutical relevance as they resemble to molecular components of 
blockbuster drugs and natural products.  
The structural motif we aimed to resemble was that of ribose (Figure 12).  
Ribose is pentose sugar that acts as an essential carbohydrate in biological systems 
and serves as part of the backbone of RNA. Additionally, phosphorylated derivatives 
of ribose that play critical roles in metabolism in biological systmes include ATP, 
NADH, cAMP and cGMP.  Some of these biological molecules have the ability to 
participate as secondary messengers in signaling pathways for metabolic processes as 





manage congestive heart failure, myalgic encephalopmyelitis as well as some other 
forms of heart disease (Teitelbaum, J. E., Johnson, C., St Cyr, J. 2006). 
 
Figure 12 
Carbacycles (left) Resembling Ribose (right) 
  
 
3.3 Results and Discussion  
  
During optimization of this reaction we explored the thermal conditions, various 
polar aprotic solvents and concentrations that could be utilized to enhance the yields we 
obtained from these reactions. Initially we aimed to investigated the thermal conditions 
and found that by heating the reactions to 80°C we were able to increase the yield 
significantly (Table 7, Entry 3).  Above this temperature we saw a decline in yield 
therefore exploring higher temperatures was not optimal for this reaction.  Next, we 
explored the potential of utilizing different solvents for this reaction but found that 
acetonitrile gave the best yields at the optimal temperature (Table 7, Entries 3, 5 and 6).  
Lastly, we wanted to determine whether diluting the concentration would encourage the 
intramolecular cycloaddition and eliminate biproduct formation.  In these studies, we 
found that employing a 0.01M concentration was ideal to promote the intramolecular 




We sought to expand the library of compounds by utilizing various enals for the 
intial nitrone formation.  Both straight alkyl chain enals as well as aromatic enals were 
selected from previous studies to be utilized in this experimentation.  We utilized N-
Benzylhydroxylamine as the nitrogen transfer agent and methacrolein as the 
dipolarophile for these reactions.  Overall the best yield was obtained utilizing aromatic 
enals with donating groups at the para position (Table 8, Entry 3).  The straight alkyl-
chain enals provided lower yields than that of the aromatic because water was not used 
during nitrone formation in an attempt to create a more robust synthesis (Table 8, Entries 
4 and 5).   
  




Table 7  








Table 8  




The dipolarophiles utilized to broaden the scope of this reaction had to exhibit 
complete selectivity for the 3-vinyl-5-formylisoxazolidine.  We attempted to utilize a 




substrates that provided the desired product for this reaction were methacrolein and 
ethylacrolein (Table 9). 
  
Table 9  
Dioplarophile Scope: Alpha-Substituted Carbonyls  
  
  
The intramolecular cycloaddition of isoxazolidines to isoxazolooxazines requires 
two nitrogen transfers agents to be employed.  In attempt to increase reactivity and 
determine the steric effects of the hydroxylamine on the intramolecular cycloaddition, we 
reacted different hydroxylamines with the 3-vinyl-5formylisoxazolidine of 





Table 10  
Hydroxylamine Scope  
  
3.4 Conclusion  
  
This method for the synthesis of isoxazolooxazines demonstrated the ability 
for N-Substituted hydroxylamine to build stereochemically dense molecules. Using 
simple enals similar structure, a regioselective and stereochemically rich fused ring 




efforts will be exploring how to cleave the nitrogen-oxygen bond of the two 
heterocyclic rings to yield the desired stereochemically dense carbacycle.  
  
3.5 Experimental  
  
Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar and 
used without further purification. Solvents were obtained from EMD Miliphore DrySol 
and degassed with nitrogen. Reactions were performed in 4-mL glass vials with magnetic 
stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and 
visualized under UV light (254 nm) or by staining with potassium permanganate 
(KMnO4). Silica flash chromatography was performed on E. Merck 230–400 mesh silica 
gel 60. Automated chromatography was performed on a ISOLERA Prime instrument with 
10 g. SNAP silica gel normal phase cartridges using a flow rate of 12.0 mL/min and a 
gradient of 0–25% Ethyl Acetate in Heptanes over 12 column volumes with UV detection 
at 254 nm. NMR spectra were recorded on Varian Mercury II 400 MHz  
Spectrometer at 24 °C in CDCl3 unless otherwise indicated. Chemical shifts are 
expressed in ppm 74 relative to solvent signals: CDCl3 (1H, 7.23 ppm; 13C, 77.0 





3.5.1. General Method for the Synthesis of Isoxazolooxazines 
In a 4- mL glass vial, 1 mMol isoxazolidine and 1.5 equivalents hydroxylamine were 
dissolved in 100 mL anhydrous acetonitrile. The reaction was stirred vigorously at 80°C 
for 24 hours. The reaction contents were then concentrated by rotary evaporation to 
afford the crude product. The crude product is filtered through silica gel over a gradient 
of 3:1 Heptanes/Ethyl Acetate over 12 column volumes to obtain the respective 
isoxazolooxazine in excellent yields  
 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C1A): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/ethyl acetate over 12 min) yielded the isoxazolooxazine 1A (86%) as a white 
solid. TLC: Rf 0.32 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 
7.25 – 7.22 (m, 10H), 7.19 (d, J = 4.4 Hz, 2H), 7.18 (d, J = 2.6 Hz, 2H), 4.49 (d, J = 7.0  
Hz, 1H), 4.01 – 3.88 (m, 4H), 3.65 (d, J = 13.0 Hz, 1H), 3.37 (s, 1H), 3.14 (dd, J = 8.3,  
1.6 Hz, 1H), 3.06 (t, J = 7.8 Hz, 1H), 2.41 (d, J = 11.3 Hz, 1H), 1.92 – 1.88 (m, 1H), 1.34  
(s, 3H). 13C NMR (125 MHz, Common NMR Solvents) δ 137.94, 136.78, 136.35, 
128.90, 128.60, 128.40, 127.99, 127.65, 81.20, 72.17, 64.93, 63.13, 62.24, 48.21, 








4,7methanoisoxazolo[4,3-d][1,2]oxazine (C1B): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/ethyl acetate over 12 min) yielded the isoxazolooxazine 1B (84%) as a white 
solid. TLC: Rf 0.36 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 
7.35 (d, J = 7.7 Hz, 3H), 7.32 – 7.21 (m, 7H), 6.85 (d, J = 8.1 Hz, 2H), 4.52 (d, J = 7.1  
Hz, 1H), 4.09 – 3.94 (m, 3H), 3.78 (s, 3H), 3.72 (d, J = 12.9 Hz, 1H), 3.41 (s, 1H), 3.22  
(d, J = 8.3 Hz, 1H), 3.11 (t, J = 7.7 Hz, 1H), 2.48 (d, J = 11.3 Hz, 1H), 1.97 (d, J = 
11.3 Hz, 1H), 1.42 (s, 3H), 1.27 (s, 1H), 0.89 (t, J = 6.3 Hz, 1H). 13C NMR (101 
MHz, Chloroform-d) δ 159.48 , 137.28 , 136.85 , 131.17 , 129.25 , 128.45 , 128.34 
, 128.21 , 127.40 , 127.30 , 113.85 , 85.47 , 81.85 , 63.55 , 63.07 , 62.45 , 60.97 , 





methanoisoxazolo[4,3-d][1,2]oxazin-3-yl)-N,N-dimethylaniline (C1C): Purification by 
automated silica gel flash chromatography (10 g cartridge, 14mL/min. 20:1 
heptanes/ethyl acetate to 1:3 heptanes/ethyl acetate over 12 min) yielded the 
isoxazolooxazine 1C (87%) as a yellow solid. TLC: Rf 0.34 (2:1 heptanes/ethyl acetate). 
1H NMR (400 MHz, Chloroform-d) δ 7.39 (d, J = 7.5 Hz, 3H), 7.33 (d, J = 7.9 Hz, 5H),  
7.26 (s, 3H), 7.24 (s, 1H), 6.71 (d, J = 8.7 Hz, 2H), 4.54 (d, J = 6.9 Hz, 1H), 4.06 (q, J =  
14.2 Hz, 3H), 3.74 (d, J = 12.9 Hz, 1H), 3.43 (s, 1H), 3.26 (d, J = 8.3 Hz, 1H), 3.19 (t, J =  
7.7 Hz, 1H), 2.95 (s, 6H), 2.52 (d, J = 11.2 Hz, 1H), 1.99 (d, J = 11.2 Hz, 1H), 1.44 




129.39 , 128.53 , 128.39 , 128.24 , 127.47 , 127.31 , 112.39 , 85.60 , 82.29 , 75.64 , 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C1D): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/ethyl acetate over 12 min) yielded the isoxazolooxazine 1D (72%) as a yellow 
oil. TLC: Rf 0.39 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ  
7.32 (dq, J = 24.9, 8.2 Hz, 10H), 4.04 (dd, J = 13.2, 6.8 Hz, 2H), 3.94 (d, J = 13.7 Hz,  
1H), 3.71 (d, J = 12.9 Hz, 1H), 3.60 – 3.55 (m, 1H), 3.29 (s, 1H), 3.07 (d, J = 8.2 Hz,  
1H), 2.73 (t, J = 7.1 Hz, 1H), 2.29 (d, J = 11.1 Hz, 1H), 1.88 (d, J = 11.1 Hz, 1H), 1.64  
(ddd, J = 15.9, 10.0, 4.9 Hz, 1H), 1.35 (s, 4H), 0.90 (t, J = 7.3 Hz, 3H). 13C NMR 
(101 MHz, Chloroform-d) δ 137.53 , 136.90 , 129.61 , 129.14 , 129.08 , 128.38 , 
128.14 , 127.32 , 127.19 , 85.32 , 80.50 , 75.08 , 63.72 , 63.58 , 62.23 , 59.59 , 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C1E): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/ethyl acetate over 12 min) yielded the isoxazolooxazine 1E (75%) as a yellow 




– 7.26 (m, 10H), 5.71 (dq, J = 13.6, 6.6 Hz, 1H), 5.52 (dd, J = 15.3, 7.6 Hz, 1H), 4.11 – 
4.00 (m, 3H), 3.95 (d, J = 13.7 Hz, 1H), 3.73 (d, J = 12.9 Hz, 1H), 3.36 (s, 1H), 3.15 (d, J 
= 8.1 Hz, 1H), 2.90 (t, J = 7.0 Hz, 1H), 2.32 (d, J = 11.2 Hz, 1H), 1.93 (d, J = 11.2 Hz, 
1H), 1.71 (d, J = 6.4 Hz, 3H), 1.37 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 137.51 
, 136.97 , 130.48 , 129.82 , 129.34 , 129.12 , 128.49 , 128.29 , 127.44 , 127.33 , 85.45 , 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C1F): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/ethyl acetate over 12 min) yielded the isoxazolooxazine 1F (78%) as a 
translucent oil. TLC: Rf 0.29 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz,  
Chloroform-d) δ 12.31 (s, 5H), 12.27 (s, 2H), 12.23 (d, J = 7.2 Hz, 4H), 12.16 (s, 3H),  
11.68 (s, 1H), 11.45 (s, 1H), 9.77 (s, 3H), 9.03 (d, J = 14.7 Hz, 1H), 8.67 (d, J = 14.7 Hz,  
1H), 8.32 (t, J = 8.5 Hz, 1H), 7.94 (dd, J = 13.1, 7.8 Hz, 1H), 7.34 (dd, J = 12.9, 9.3 Hz,  
1H), 6.84 (s, 3H), 6.59 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 141.97 , 137.88 ,  
137.39 , 135.34 , 132.70 , 129.30 , 129.12 , 129.08 , 128.96 , 128.75 , 128.31 , 
128.23 , 128.13 , 127.04 , 126.60 , 80.17 , 69.92 , 59.72 , 44.11 , 31.97 , 29.71 , 











4,7methanoisoxazolo[4,3-d][1,2]oxazine (C2A): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/EtOAc over 12 min) yielded the isoxazolooxazine 2A (86%) as a white solid. 
TLC: Rf 0.32 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 7.25 –  
7.22 (m, 10H), 7.19 (d, J = 4.4 Hz, 2H), 7.18 (d, J = 2.6 Hz, 2H), 4.49 (d, J = 7.0 Hz,  
1H), 4.01 – 3.88 (m, 4H), 3.65 (d, J = 13.0 Hz, 1H), 3.37 (s, 1H), 3.14 (dd, J = 8.3, 1.6  
Hz, 1H), 3.06 (t, J = 7.8 Hz, 1H), 2.41 (d, J = 11.3 Hz, 1H), 1.92 – 1.88 (m, 1H), 1.34 (s,  
3H). 13C NMR (125 MHz, Common NMR Solvents) δ 137.94, 136.78, 136.35, 128.90, 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C2B): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/EtOAc over 12 min) yielded the isoxazolooxazine 2B (85%) as a yellow oil. 
TLC: Rf 0.33 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 7.41 –  




(d, J = 12.9 Hz, 1H), 3.50 (s, 1H), 3.33 (d, J = 8.3 Hz, 1H), 3.22 (t, J = 7.5 Hz, 1H), 2.40 
(d, J = 11.3 Hz, 1H), 2.14 (d, J = 11.3 Hz, 1H), 1.97 (dd, J = 14.5, 7.3 Hz, 1H), 1.80 (dd, 
J = 14.4, 7.2 Hz, 1H), 1.33 (s, 1H), 1.11 (td, J = 7.4, 1.4 Hz, 3H). 13C NMR (101 MHz,  
Chloroform-d) δ 139.47 , 137.28 , 136.78 , 129.26 , 129.05 , 128.37 , 128.34 , 
128.11 , 127.89 , 127.32 , 127.18 , 126.72 , 88.79 , 82.12 , 74.71 , 63.47 , 62.94 , 
62.12 , 60.64 , 30.81 , 29.62 , 21.21 , 8.77 . 
 




4,7methanoisoxazolo[4,3-d][1,2]oxazine (C3A): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/EtOAc over 12 min) yielded the isoxazolooxazine 3A (86%) as a white solid. 
TLC: Rf 0.32 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 7.25 –  
7.22 (m, 10H), 7.19 (d, J = 4.4 Hz, 2H), 7.18 (d, J = 2.6 Hz, 2H), 4.49 (d, J = 7.0 Hz,  
1H), 4.01 – 3.88 (m, 4H), 3.65 (d, J = 13.0 Hz, 1H), 3.37 (s, 1H), 3.14 (dd, J = 8.3, 1.6  
Hz, 1H), 3.06 (t, J = 7.8 Hz, 1H), 2.41 (d, J = 11.3 Hz, 1H), 1.92 – 1.88 (m, 1H), 1.34 (s,  
3H). 13C NMR (125 MHz, Common NMR Solvents) δ 137.94, 136.78, 136.35, 128.90, 
128.60, 128.40, 127.99, 127.65, 81.20, 72.17, 64.93, 63.13, 62.24, 48.21, 42.84, 22.95.  










4,7methanoisoxazolo[4,3-d][1,2]oxazine (C3B): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/EtOAc over 12 min) yielded the isoxazolooxazine 3B (76%) as a white solid. 
TLC: Rf 0.34 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 7.33 –  
7.24 (m, 10H), 4.53 (d, J = 6.4 Hz, 1H), 4.03 (d, J = 13.0 Hz, 1H), 3.72 (d, J = 12.9 Hz,  
1H), 3.43 (d, J = 10.2 Hz, 2H), 3.15 (t, J = 7.5 Hz, 1H), 2.50 (s, 1H), 2.42 (s, 1H), 
1.94 (s, 2H), 1.74 (s, 3H), 1.63 (s, 2H), 1.46 (s, 3H), 1.34 (s, 4H). 13C NMR (101 
MHz, Chloroform-d) δ 140.02 , 136.90 , 129.23 , 128.44 , 128.00 , 127.37 , 127.01 
, 85.87 , 82.01 , 72.21 , 65.29 , 63.96 , 62.44 , 60.46 , 34.14 , 32.47 , 27.12 , 26.01 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C3C): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/EtOAc over 12 min) yielded the isoxazolooxazine 3C (80%) as a white solid. 
TLC: Rf 0.36 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 7.33  
(dd, J = 13.1, 5.1 Hz, 8H), 7.26 (s, 2H), 4.54 (d, J = 7.8 Hz, 1H), 4.05 (d, J = 12.9 Hz,  
1H), 3.73 (d, J = 12.9 Hz, 1H), 3.43 (s, 1H), 3.13 (t, J = 7.9 Hz, 1H), 2.94 (d, J = 9.9 Hz,  
1H), 2.80 (s, 4H), 2.47 (d, J = 11.2 Hz, 1H), 2.00 (d, J = 11.3 Hz, 1H), 1.48 (s, 3H). 




128.24 , 127.36 , 126.95 , 85.15 , 82.00 , 63.21 , 62.35 , 61.80 , 45.93 , 33.94 , 29.64 , 





4,7methanoisoxazolo[4,3-d][1,2]oxazine (C3D): Purification by automated silica gel 
flash chromatography (10 g cartridge, 14mL/min. 20:1 heptanes/ethyl acetate to 1:3 
heptanes/EtOAc over 12 min) yielded the isoxazolooxazine 3C (78%) as a white solid.  
TLC: Rf 0.35 (2:1 heptanes/ethyl acetate). 1H NMR (400 MHz, Chloroform-d) δ 7.35 (d,  
J = 5.2 Hz, 8H), 7.27 (d, J = 6.9 Hz, 2H), 4.57 (d, J = 7.6 Hz, 1H), 4.04 (d, J = 12.8 Hz,  
1H), 3.74 (d, J = 12.9 Hz, 1H), 3.46 (d, J = 9.9 Hz, 2H), 3.17 (t, J = 8.2 Hz, 1H), 
2.42 (d, J = 11.5 Hz, 1H), 1.99 (d, J = 11.5 Hz, 1H), 1.52 (s, 3H), 1.16 (s, 9H). 
13C NMR (101 MHz, Chloroform-d) δ 139.74 , 136.73 , 129.22 , 128.41 , 127.88 
, 127.37 , 126.72 , 86.11 , 81.55 , 69.79 , 63.83 , 62.57 , 61.96 , 59.40 , 34.75 , 
26.52 , 16.27 .  
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